Does DABIGATRAN ETEXILATE Cause Epistaxis? 531 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 531 reports of Epistaxis have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.4% of all adverse event reports for DABIGATRAN ETEXILATE.
531
Reports of Epistaxis with DABIGATRAN ETEXILATE
1.4%
of all DABIGATRAN ETEXILATE reports
105
Deaths
360
Hospitalizations
How Dangerous Is Epistaxis From DABIGATRAN ETEXILATE?
Of the 531 reports, 105 (19.8%) resulted in death, 360 (67.8%) required hospitalization, and 55 (10.4%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Epistaxis Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB